Why are Black people more likely to develop glaucoma? Scientists discover new clues – The Mercury News
![](https://newsnetdaily.com/wp-content/uploads/2024/04/LIFE-HEALTH-GLAUCOMA-BLACK-DMT.jpg)
![](https://newsnetdaily.com/wp-content/uploads/2024/04/LIFE-HEALTH-GLAUCOMA-BLACK-DMT.jpg)
Tom April | The Philadelphia Inquirer (TNS)
A team led by scientists at the University of Pennsylvania has discovered three genetic variants that offer the first strong clues about why glaucoma disproportionately affects black people.
The variants are common among people of African descent and are associated with a significantly higher risk of developing the sight-robbing disease, researchers found in their study of more than 11,000 volunteers, including 6,300 from the region from Philadelphia.
Further research is needed to determine whether these variants – each made up of a single “letter” of the 3 billion letter pairs that describe the human genome – play a direct role in the onset of glaucoma. But if they hold up to scrutiny, the findings could one day be used to develop better treatments and identify people who might benefit from them, said Shefali Setia Verma, one of the study’s lead authors and an assistant professor. at Penn’s Perelman School of Medicine.
“The idea is that this can help identify people who are most at risk before symptoms appear,” she said.
Previous studies have discovered more than 170 other genetic variants involved in glaucoma, a disease in which the optic nerve is damaged, often due to increased pressure inside the eye. But most of these studies have been conducted in white or Asian populations, despite the fact that glaucoma is more common in black people and, when it occurs, is more likely to lead to blindness.
And most of the genetic variants discovered in those previous studies were found to play little or no role in getting the disease in Black people, illustrating the need for diversity in the populations studied, said Penn physician-scientist Joan M. O’Brien. .
“It was a hugely unmet need,” she said.
Gaining the trust of black patients
That’s what prompted O’Brien, Verma and their colleagues to launch the new study, which is one of the first — and by far the largest — conducted among Black people.
O’Brien blamed the lack of studies in part on the legitimate reluctance of many blacks toward medical research, citing examples of misconduct such as the Tuskegee experiment in which black men were not treated for syphilis.
Persistent bias in medicine continues to contribute to mistrust. For example, black patients are less likely than white patients to receive painkillers and less likely to be admitted to the hospital from the emergency room. Until recently, they had to wait longer than white patients to get a kidney transplant.
“There are clearly reasons why individuals of African descent are wary of academics, medicine and many things related to science,” she said. “That doesn’t exempt us from trying to engage people of African descent.”
So she and her co-authors embarked on an unusual campaign to recruit volunteers, spreading the word by conducting eye exams at predominantly black churches, community centers and health fairs. Eydie Miller-Ellis, a Pennsylvania ophthalmologist and author of the Black study, also promoted the study on the Black-owned radio station WURD.
They ended up with 11,275 study participants, including the 6,300 enrolled by Penn doctors in the Philadelphia area. The others came from elsewhere in the United States, as well as Ghana and Nigeria, recruited by collaborators at other institutions.
The scientists began by comparing the genomes of study participants with glaucoma with those of participants who did not, identifying dozens of genetic variants that differed between the two groups.
Then I narrowed that list down to the final three by conducting a series of laboratory studies on human cells. They also validated their results by comparing them to other genetic databases, including Penn Medicine’s own BioBank, a repository of blood and genetic samples of which 17% came from Black people.
Increased risk of glaucoma
All three variants were found in non-coding regions of the genome – what was once incorrectly called “junk DNA”, or segments of DNA located outside of genes. But as scientists have discovered in many other cases, these three variants, although not part of any gene, appear to play a role in the activity of neighboring genes.
One of the variants was associated with a 75% increase in the risk of glaucoma. The other two were each linked to a 25% increase in disease risk.
All three variants appear to play some causal role in the disease, but more work is needed to be sure. O’Brien, director of the Penn Center for Genetics of Complex Disease, hopes that one day the results can be incorporated into a rapid test, suitable for use in a primary care practice.
Such a test would allow doctors to identify and counsel at-risk patients before they become aware of symptoms. People with the condition are often unaware that they have it because it usually begins with a decline in peripheral vision, which patients may not notice at first.
Genetic discoveries could also guide the development of better drugs, O’Brien said. Currently, doctors treat the disease by trying to reduce the pressure inside patients’ eyes, first with medication and later, if necessary, with surgery.
But these tactics don’t work for everyone whose disease is caused by high eye pressure, O’Brien said. And in some cases, the disease can occur in people with normal eye pressure.
“We know it’s not just about pressure,” she said. “But it’s the only treatment we have to give.”
©2024 The Philadelphia Inquirer, LLC. Visit enquirer.com. Distributed by Tribune Content Agency, LLC.
California Daily Newspapers